A randomized study of melphalan 200 mg/m(2) vs 280 mg/m(2) as a preparative regimen for patients with multiple myeloma undergoing auto-SCT
一项随机研究比较了马法兰 200 mg/m² 与 280 mg/m² 作为多发性骨髓瘤患者自体干细胞移植预处理方案的疗效。
期刊:Bone Marrow Transplantation
影响因子:5.2
doi:10.1038/bmt.2015.211
Bensinger, W I; Becker, P S; Gooley, T A; Chauncey, T R; Maloney, D G; Gopal, A K; Green, D J; Press, O W; Lill, M; Ifthikharuddin, J J; Vescio, R; Holmberg, L A; Phillips, G L
